 Connection
James Bridges to Dose-Response Relationship, Drug
This is a "connection" page, showing publications James Bridges has written about Dose-Response Relationship, Drug.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.109 |
|
|
|
-
Natsch A, Griem P, Irizar A, Bridges J, Vey M, Lee I, Api AM, Kern P, Kimber I. Derivation of a Point of Departure using NAMs for application in Quantitative Risk Assessment of fragrance materials. Regul Toxicol Pharmacol. 2026 May; 167:106052.
Score: 0.043
-
Bridges JP, Wert SE, Nogee LM, Weaver TE. Expression of a human surfactant protein C mutation associated with interstitial lung disease disrupts lung development in transgenic mice. J Biol Chem. 2003 Dec 26; 278(52):52739-46.
Score: 0.037
-
Api AM, Basketter D, Bridges J, Cadby P, Ellis G, Gilmour N, Greim H, Griem P, Kern P, Khaiat A, O'Brien J, Rustemeyer T, Ryan C, Safford B, Smith B, Vey M, White IR. Updating exposure assessment for skin sensitization quantitative risk assessment for fragrance materials. Regul Toxicol Pharmacol. 2020 Dec; 118:104805.
Score: 0.030
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|